Policy announcement

FDA Told a Promising ADC: Not Yet.

Retatrutide Isn’t Approved. Online, ‘Reta’ Is Already a Weight-Loss Brand

Can Belgium Turn Routine GP Data Into Cardiovascular Prevention?

MOGAD Is Close to Its First Real Treatment

Epilepsy Innovation Just Hit a Safety Wall

The Recall Is Still In The Freezer.

Thailand Beat Rubella.

Outbreaks Ignore Borders.

Sanfilippo’s Approval Path Is Being Built Before Approval
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
